Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0750 - PURPOSE AND SCOPE
The purpose and scope of parts 4615.0750 to 4615.0760 is to describe the responsibilities of the Minnesota Department of Health to assure that persons diagnosed as having hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and/or congenital adrenal hyperplasia will:
(1) have access to approved
laboratory treatment control tests when available;
(2) have necessary financial assistance for
treatment of diagnosed cases when indicated; and
(3) be included in a registry of cases for
the purpose of coordinating follow-up services.
Notes
Statutory Authority: MS s 144.125; 144.128
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.